The therapeutic and the prophylactic effects of a vaccine against vaginal trichomoniasis were studied. The cure rate was 93% after 3 months and 90% after 6 months. The big advantage of this immunotherapy over metronidazole preparations is protection of the patient against recurrence and reinfection.